The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...

GRAND RAPIDS, Michigan — March is National Blood Clot Awareness Month, and this past year, Corewell Health's Butterworth Hospital has been named a Center of Excellence by the National Blood Clot ...

Every year, nearly 900,000 Americans are affected by venous thromboembolism (VTE), a condition in which blood clots form in ...

According to CDC estimates, as many as 900,000 people are affected by blood clots each year in the United States. Although serious, this medical condition is both preventable and treatable, if ...

The Johns Hopkins Armstrong Institute for Patient Safety and Quality leads national VTE prevention efforts through its Venous Thromboembolism (VTE) Collaborative, which aims to advance evidence-based ...

March 13 (Reuters) - A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same ...

The Johns Hopkins Armstrong Institute for Patient Safety and Quality offers a video and handout aimed at helping patients better engage in preventing blood clots. The two-page handout, that covers ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to prevent blood clots in patients with a serious condition called chronic ...

Blood clots can be dangerous and lead to complications like heart attacks, strokes, and blood clots in the lungs. A study published in Life Metabolism examined the effects of intermittent fasting on ...

Her passing underscores the urgent, preventable risk of cancer-associated blood clots — the second leading cause of death in people with cancer. Blood clots are one of the most serious and preventable ...